Phase II data of brigantinib for relapsed and metastatic NSCLC released
Data from the pivotal Phase 2 ALTA clinical trial evaluating brigatinib in patients with crizotinib-refractory, anaplastic lymphoma…
Browsing: drug trial
Cancer Research UK launches new trial to test drug against resistant bladder cancer
A clinical trial to test a drug which may stop bladder cancers becoming resistant to…
Drug targeting BRAF mutation slows thyroid cancer
In the era of precision medicine, targeting the mutations driving cancer growth, rather than the…